Arunjyoti Bio Ventures Ltd

Arunjyoti Bio Ventures Ltd has announced its 40th Annual General Meeting (AGM) will be held on August 12, 2026, at 11:00 a.m. via Video Conferencing/Other Audio Visual Means (OAVM). The meeting agenda includes the adoption of the Audited Balance Sheet and Profit & Loss statement for FY 2025-26, along with the Directors' and Auditors' reports. Additionally, a director retiring by rotation will be considered for re-appointment. A key item of special business is the proposed appointment of M/s. Vivek Surana & Associates as Secretarial Auditors for a term of up to five consecutive years, from April 1, 2026, to March 31, 2031.

Arunjyoti Bio Ventures Limited announced a significant change in its corporate identity, proposing to change its name to Pasura Industries Limited, subject to member approval. This rebranding is part of a broader set of resolutions approved at the Board Meeting held on July 9, 2026. The company also approved un-audited financial results for the quarter ended June 30, 2026, and a limited review report. Key management changes include the resignation of Manoj Parakh & Associates as Secretarial Auditor and the appointment of Vivek Surana & Associates. Additionally, the board decided to waive recovery of excess managerial remuneration paid to two Whole-time Directors and revised their remuneration packages. The 40th Annual General Meeting is scheduled for August 12, 2026.

Arunjyoti Bio Ventures Limited announced its un-audited financial results for the quarter ended June 30, 2026. The board meeting also approved a change in the company's name to Pasura Industries Limited, subject to shareholder approval. Additionally, the board approved the appointment of new secretarial auditors and the waiver of recovery of excess managerial remuneration paid to two Whole-time Directors for FY25-26. Revisions in remuneration for three Whole-time Directors were also approved.

Arunjyoti Bio Ventures Ltd has scheduled a Board of Directors meeting for July 9, 2026. The primary agenda item is to consider and approve the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report. The meeting will take place at the company's registered office in Madhapur, Telangana. Other business may also be discussed with the permission of the Chair.

Arunjyoti Bio Ventures Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter ending June 30, 2026. This measure is to prevent insider trading during the period leading up to and immediately following the announcement of financial results. A board meeting will be convened to approve these results, with a separate intimation to be sent to the exchange regarding the meeting notice.

Arunjyoti Bio Ventures Ltd reported audited financial results for the quarter and year ended March 31, 2026. The company's total income for the year stood at ₹2,787.24 Lakhs, while total expenses amounted to ₹3,027.61 Lakhs, resulting in a net loss after tax of ₹453.61 Lakhs. The board also approved the write-off of outstanding Debtors and Creditors amounting to ₹273.65 Lakhs.

Arunjyoti Bio Ventures Ltd has announced the postponement of its Board Meeting, initially scheduled for May 12, 2026, to May 13, 2026. The meeting will still address the consideration and approval of Audited Financial Results, as previously indicated in earlier intimations dated May 1, 2026, and May 5, 2026. The agenda remains unchanged, and the meeting will take place at the company's registered office.

Arunjyoti Bio Ventures Ltd has rescheduled its Board Meeting to May 12, 2026, to consider and approve the Audited Financial Results. The meeting was initially scheduled for May 8, 2026, but was postponed due to unavoidable reasons. The agenda remains the same as previously intimated.

Arunjyoti Bio Ventures Ltd has scheduled a Board of Directors meeting on May 8, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will take place at the company's registered office in Telangana.

Chennupati Sarath Kumar has disclosed the sale of 5,425,516 equity shares of Arunjyoti Bio Ventures Ltd. The transaction, executed through open market operations between April 13 and April 16, 2026, reduced his shareholding from 7.57% (14,101,138 shares) to 4.66% (8,675,622 shares) of the company's total equity. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.